Elements Contrast Clearance Analysis
Brainlab's Elements Contrast Clearance Analysis is an MRI-based methodology designed to differentiate regions of contrast clearance and accumulation in brain tumor datasets. This high-resolution analysis provides additional insights to support ongoing assessment and decision-making in clinical specialties such as radiosurgery, radiation oncology, neurosurgery, neuro-oncology, and neuroradiology. The process involves acquiring two standard 3D T1-weighted MRIs, one approximately 5 minutes and another 60 to 105 minutes after the injection of a standard dose of contrast agent. The first series is subtracted from the second to generate volumetric maps that distinguish regions of contrast clearance (depicted in blue) from contrast accumulation (depicted in red). These results enable clinicians to assess radiation effects versus tumor regrowth, facilitating more informed decisions for initial and follow-up treatments.
Learn more
Merlin CardioMotion
The CardioMotionTM echo analysis and reporting software from Merlin and available from CDN in Australia changes the game and changes the way you are supporting the rapid identification of cardiac issues. Intended for emergency medicine, CCU/ICU, oncology departments, medical center clinicians, ultrasound departments, cardiology departments, or regional and remote sites where point-of-care devices are used. Also beneficial in cardiac monitoring of clinical trials. Merlin CardioMotionTM is unique as it works effectively with slow frame rate echo clips without the need for an ECG trace for detection and as such is suitable for use with clips from lower specification ultrasound machines. Using revolutionary image processing technology Merlin CardioMotionTM is based on a platform of proprietary algorithms that enable automatic detection of the ventricular wall and its borders. This provides you with a rapid and accurate quantitative assessment of your patient’s heart’s dynamic performance.
Learn more
MIStar
Apollo Medical Imaging Technology is a clinically-driven medical imaging software company specializing in the creation of advanced image processing software for clinical and research applications. Their flagship product, MIStar, is a fast, economical, and easy-to-use software package that provides a broad spectrum of advanced functions and cost-effective cross-modality solutions for clinicians and the OEMs that serve them. MIStar supports various imaging modalities, including CT, MR, NM, and PET, and offers advanced modules such as CT Perfusion for stroke, brain tumor, body tumor, liver, kidney, and prostate; DSC-MRI for stroke; DCE-MRI for brain tumor, breast, body tumor, liver, kidney, and prostate; DWI & ADC; DTI Fiber Tractography; NM Renogram Analysis; and Image Fusion. The software features data access and image input through DICOM networking functions, an intuitive clinical database, and easy anonymization and archiving.
Learn more
Tempus
Tempus AI is a leading health technology company headquartered in Chicago, Illinois. Specializing in artificial intelligence and precision medicine, Tempus aims to revolutionize patient care by leveraging data and AI to develop personalized treatment plans across various medical fields, including oncology, cardiology, radiology, and depression. The company's comprehensive platform integrates genomic sequencing, clinical data, and AI-driven analytics to provide actionable insights for healthcare providers and researchers. We deliver a comprehensive view of your patients through our tissue and liquid tests, DNA and RNA sequencing, somatic and germline tests, tumor-normal matched profiling, and MRD and monitoring test options. We offer a fast, reliable platform for ordering Tempus tests, accessing patient insights, and utilizing our AI-driven technologies seamlessly. The first generative AI-enabled clinical assistant that provides access to patient insights directly at your fingertips.
Learn more
